63 pages •
By Infiniti Research Limited
• Jun 2017
The offers a wide range of devices and kits for autoimmune diseases worldwide.
156 pages •
By Infiniti Research Limited
• Jun 2016
Develops drugs for oncology, bone and joint diseases, central nervous system (CNS) disorders, and autoimmune diseases.
127 pages •
By Mordor Intelligence LLP
• Apr 2018
- Revenue Share (%), by Business Segment, 2017
It is one of the world' s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.
70 pages •
By Infiniti Research Limited
• May 2017
Kaposi sarcoma induced due to HIV/ AIDS is one of the most common causes of the disease and acts as a major driver for the market.
539 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
543 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
545 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
564 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
546 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
552 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
552 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
547 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
544 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
547 pages •
By GlobalData
• May 2017
THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.
76 pages •
By Igate Research
• May 2015
While oncology has been one of the most active therapeutic areas for drug development, for drugmakers the new cancer drugs have proven far more difficult to gain approval than medicines for infectious and autoimmune diseases.
272 pages •
By Asia Market Information & Development Company
• Mar 2018
Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.
256 pages •
By Asia Market Information & Development Company
• Mar 2018
Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.
121 pages •
By Asia Market Information & Development Company
• Mar 2018
Many of the immunosuppressive drugs used in the treatment of autoimmune diseases such as corticosteroids, and organ transplant rejection (cyclosporine, tacrolimus) work by inhibiting the production of IL-## by antigen-activated T cells.
120 pages •
By Asia Market Information & Development Company
• Feb 2018
Many of the immunosuppressive drugs used in the treatment of autoimmune diseases such as corticosteroids, and organ transplant rejection (cyclosporine, tacrolimus) work by inhibiting the production of IL-## by antigen-activated T cells.
155 pages •
By GBI Research
• Dec 2017
Genes & Diseases; ##(##): ##-## Cancer Network.
239 pages •
By Asia Market Information & Development Company
• Mar 2018
Many of the immunosuppressive drugs used in the treatment of autoimmune diseases such as corticosteroids, and organ transplant rejection (cyclosporine, tacrolimus) work by inhibiting the production of IL-## by antigen-activated T cells.
244 pages •
By Asia Market Information & Development Company
• Mar 2018
Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.
231 pages •
By Asia Market Information & Development Company
• Mar 2018
Roche is the world leader in in-vitro diagnostics and drugs for cancer Page## Chapter VII SKIN CANCER TREATMENT DRUGS PRODUCER DIRECTORY and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metaboli
235 pages •
By Asia Market Information & Development Company
• Feb 2018
Many of the immunosuppressive drugs used in the treatment of autoimmune diseases such as corticosteroids, and organ transplant rejection (cyclosporine, tacrolimus) work by inhibiting the production of IL-## by antigen-activated T cells.
58 pages •
By Global Industry Analysts
• Jan 2016
88 pages •
By Asia Market Information & Development Company
• Mar 2018
Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.
80 pages •
By Asia Market Information & Development Company
• Mar 2018
Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.
608 pages •
By GlobalData
• Nov 2016
THIS STUDY INCLUDED BOTH PD-L## NEGATIVE TWO WEEKS) OR DOCETAXEL (##MG/ M (##%) AND PD-L## POSITIVE (##%) PATIENTS, BUT EXCLUDED PATIENTS WITH AUTOIMMUNE DISEASE, SYMPTOMATIC ILD, AND UNTREATED BRAIN METASTASIS.
123 pages •
By Infiniti Research Limited
• Mar 2015
Drivers and their Impact Driver Hospitals Pharmaceutical Stores Increase in Prevalence of Breast Cancer Low Low Unmet Medical Needs ## ## ## ## ## High High Low Low ## ## ## ## ## High High Increase in Prevalence of Breast Cancer Americas Low Low ## ## ## ## ## High High Low Low
106 pages •
By Infiniti Research Limited
• Dec 2015
- BRISTOL-MYERS SQUIBB: KEY TAKEAWAYS
- MARKET SHARE ANALYSIS 2014
The company develops drugs, using the genomic antibody drug discovery approach, in the areas of oncology, bone and joint diseases, CNS disorders, autoimmune diseases, and others.
